As of May 2024 Renovaro Biosciences has a market cap of $0.21 Billion. This makes Renovaro Biosciences the world's 6885th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.21 B | 1.92% |
2023 | $0.21 B | 269.82% |
2022 | $57.17 M | -85.1% |
2021 | $0.38 B | 178.14% |
2020 | $0.13 B | -40.65% |
2019 | $0.23 B | -14.39% |
2018 | $0.27 B | 316.41% |
2017 | $65.2 M | 355.99% |
2016 | $14.29 M | -61.54% |
2015 | $37.17 M |
On May 2nd, 2024 the market cap of Renovaro Biosciences was reported to be: